Big news for pharma industry in India as popular painkiller Saridon, which was banned in India since September is back. For those who don’t know, Saridon was sold by Piramal Enterprises Ltd. (PEL) and now the Supreme Court has lifted the ban from PEL to continue with the distribution. Below are the details about the ban and why it has been removed:
Why Saridon was banned
In September 349 companies had been banned by the Central Drugs Standard Control Organisation (CDSCO). These included a combination of medicines like Aceclofenac+ Paracetamol+ Rabeprazole, Nimesulide + Cetirizine + Caffeine, and Paracetamol + Cetirizine + Caffeine.
Getting free from ban
According to reports from The Hindu, the ban from Saridon has been removed as the Supreme court has exempted the formulation of Saridon from the list of FDCs.
Talking about the decision, Nandini Piramal, the Executive Director of Piramal Enterprises Limited, said “Saridon is a heritage brand trusted by customers for the last 50 years in India. This exemption from the banned list of FDCs validates our intent to serve our customers with the highest levels of integrity.”
She also said, “We continue to expand our healthcare product portfolio with an aim to be amongst the top three OTC (over-the-counter) product companies in India by 2020,” in a stock exchange filing.
Nandini’s quotes: Trak.in
The brand Sardon
Saridon is a trusted name in India market and its ad jingles have always been very popular. A study by AC Neilson, PEL has revealed that 31 tablets of Saridon are sold every second in India.
